Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation TCT 2022

TCT 305: The effect of diltiazem versus placebo on microvascular dysfunction assessed by serial continuous thermodilution measurements: results of the EDIT-CMD trial.

Presenter: Tijn Jansen

September 19, 2022

Presentation TCT 2022

TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan

Presenter: Shinichiro Masuda

September 19, 2022

Presentation TCT 2022

TCT 303: Continuous versus bolus thermodilution derived CFR and MRR and their association with symptoms of CMD: a head-to-head comparison

Presenter: Tijn Jansen

September 19, 2022

Presentation TCT 2022

TCT 302: MRR by Continuous Thermodilution is not Influenced by the Ray Flow Catheter Effect on Coronary Resistance

Presenter: Alejandro Gutierrez-Barrios

September 19, 2022

Presentation TCT 2022

TCT 301: The role of the collateral circulation in stable coronary artery disease: a placebo-controlled study in patients with stable angina.

Presenter: Christopher Rajkumar

September 19, 2022

Presentation TCT 2022

TCT 300: The impact of coronary microvascular dysfunction on fractional flow reserve and resting full-cycle ratio discordance in the assessment of borderline coronary lesions

Presenter: Piotr Szolc

September 18, 2022

Presentation TCT 2022

TCT 298: Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function on Cardiovascular Death

Presenter: David Hong

September 18, 2022

Presentation TCT 2022

TCT 297: Prevalence of Coronary Microvascular Disease in Patients with Non-Obstructive Coronary Artery Disease

Presenter: Carlos Collet

September 18, 2022

Presentation TCT 2022

TCT 296: Post-Spastic Flow Recovery Time to Document Vasospasm Induced Ischemia during Acetylcholine Provocation Testing.

Presenter: Janneke Woudstra

September 18, 2022

Presentation TCT 2022

TCT 295: Periprocedural Angiography-Derived Index of Microvascular Resistance in Patients With Multivessel Disease: Perspective From Multivessel TALENT Trial

Presenter: SHIGETAKA KAGEYAMA

September 18, 2022

Advertisement

TCT 305: The effect of diltiazem versus placebo on microvascular dysfunction assessed by serial continuous thermodilution measurements: results of the EDIT-CMD trial.

TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan

TCT 303: Continuous versus bolus thermodilution derived CFR and MRR and their association with symptoms of CMD: a head-to-head comparison

TCT 302: MRR by Continuous Thermodilution is not Influenced by the Ray Flow Catheter Effect on Coronary Resistance

TCT 301: The role of the collateral circulation in stable coronary artery disease: a placebo-controlled study in patients with stable angina.

TCT 300: The impact of coronary microvascular dysfunction on fractional flow reserve and resting full-cycle ratio discordance in the assessment of borderline coronary lesions

TCT 298: Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function on Cardiovascular Death

TCT 297: Prevalence of Coronary Microvascular Disease in Patients with Non-Obstructive Coronary Artery Disease

TCT 296: Post-Spastic Flow Recovery Time to Document Vasospasm Induced Ischemia during Acetylcholine Provocation Testing.

TCT 295: Periprocedural Angiography-Derived Index of Microvascular Resistance in Patients With Multivessel Disease: Perspective From Multivessel TALENT Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content